Currently, there are no large-scale clinical trials specifically designed to evaluate GLP-1 medications for joint pain or osteoarthritis treatment
[DOI] [PubMed] [Google Scholar] 62.Perovic D., Kolenc D., Bilic V., Somun N., Drmic D., Elabjer E., Buljat G., Seiwerth S., Sikiric P
Moreover, recent findings have indicated that increasing the level of NAD + in cells can assist in the elimination of oxidative stress by activating the SIRT1 deacetylation of the NRF2 pathway (Wei et al
Report the issue to the FDA
Ward told Science Media Centre that the study wasn't designed to assess all possible side-effects of the treatments
Chiba Y, Danno S, Suto R, Suto W, Yamane Y, Hanazaki M, et al